Partnership
Boost adherence and outcomes in women’s chronic health
Improve women’s health outcomes by boosting adherence through AI-driven mental health support.
Mential is a precision clinical infrastructure for mental health, combining digital twins, clinical AI and FHIR R4 structured data to enable prevention, treatment and measurable impact at scale.
We partner with pharmaceutical and life sciences companies to support mental health endpoints in clinical trials, generate Real-World Evidence (RWE), and co-develop Digital Therapeutics (DTx) as companions or standalone interventions — with validated outcomes across 50,000+ patients.
Our modular platform covers the full data lifecycle: clinical data structuring (FHIR R4), population analytics and RWE generation, continuous patient monitoring with 1,300+ clinical biomarkers, and AI-powered personalized digital treatment.
We are currently open to collaborations in: digital biomarker co-development, RWE generation for women's health indications (maternity, menopause, endometriosis, PCOS), DTx co-development and commercialization, and integration into existing pharmacological treatment protocols.
Backed by EIT Health, ENISA and Google for Startups. CE/MDR certification pathway underway (SaMD). Active pilots in Europe and LATAM.
Sector
Partnership
Boost adherence and outcomes in women’s chronic health
Improve women’s health outcomes by boosting adherence through AI-driven mental health support.
Service
AI-powered mental health support tailored for women
Personalized AI mental health solutions designed for women’s unique needs, from maternity to menopause.
Partnership
Clinical validation and real-world evidence generation
Partner with Mential to generate clinical evidence and RWE for Digital Therapeutics in women’s mental health.
Partnership
Digital twin technology for precision mental health
Leverage Mential’s digital twin to deliver precision mental health with predictive, personalized care.